pacific biosciences

Genetic Future

Category archives for pacific biosciences

Dan Koboldt has a very nice recap of the various sequencing technologies presented at last week’s Advances in Genome Biology and Technology meeting. I totally agree with his central point: Something had been bothering me about the sequencing-company presentations this year, and I finally realized what it was. During AGBT 2009, every player was gunning…

The main theme of this year’s Advances in Genome Biology and Technology meeting should come as no surprise to regular readers: sequencing. Generating as many bases of DNA sequence as quickly, cheaply and accurately as possible is the goal of the moment, and the number of companies jostling to achieve that goal is growing rapidly.…

Stephen Turner from Pacific Biosciences gave a dramatic presentation this afternoon launching PacBio’s new third-generation sequencing instrument. The room was packed for the seminar, with a palpable buzz, and Turner’s presentation was preceded by a theatrical introduction from PacBio CEO Hugh Martin.  The crescendo of Turner’s presentation was the unveiling of a video showing the…

Belated news from AGBT

I’ve been remiss in blogging from the Advances in Genome Biology and Technology meeting here in Marco Island, Florida, primarily due to some panic-stricken last-minute changes to the slides for my own presentation last night. Fortunately the conference has been extremely well-covered by others: Sanger colleague Luke Jostins has blog posts up summarising day 1…

The big news from the JP Morgan investment conference today is the announcement of a brand new shiny sequencing machine from Illumina, the HiSeq 2000. The new machine boasts an impressive set of statistics, and looks likely to gradually replace Illumina’s GAIIx as the workhorse of most modern sequencing facilities. So, how excited should we…

The Gene Sherpa predicts that Complete Genomics will win the Archon X Prize in Genomics in 2010. In the comments, Keith Robison is wisely skeptical. I agree with Keith – it’s unlikely that the X Prize will be won this year, and if it is the winner is unlikely to be Complete Genomics. For those…